Navigation Links
New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
Date:1/5/2011

RIDGEFIELD, Conn., Jan. 5, 2011 /PRNewswire/ -- Results of a post-hoc analysis of the RE-LY® trial among patients with non-valvular atrial fibrillation (NVAF) undergoing cardioversion, a treatment to convert an abnormal heartbeat back to normal sinus rhythm, were published online on Jan. 3 in Circulation.(1)  Stroke and systemic embolism and major bleeding episodes within 30 days of the cardioversion were the major outcome measures.  The analysis reported that rates of stroke and systemic embolism and major bleeding were low and comparable to warfarin in cardioverted patients receiving Pradaxa® (dabigatran etexilate mesylate) 150mg capsules,(1) an oral anticoagulant recently approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and systemic embolism in patients with NVAF.(2)

In RE-LY, a total of 1,983 cardioversions were performed in 1,270 patients, with similar numbers in each treatment group (647 in the dabigatran 110mg* group, 672 in the PRADAXA 150mg group and 664 in the warfarin group).(1)  Rates of stroke and systemic embolism within 30 days of cardioversion were low and did not differ significantly between treatment arms (0.77%, 0.3% and 0.6%, respectively; dabigatran 110mg vs. warfarin, p=0.71; PRADAXA 150mg vs. warfarin, p=0.45),(1) though the RE-LY trial and this subgroup analysis were not powered to demonstrate statistical significance.  Similarly, major bleeding within 30 days of cardioversion was infrequent and comparable between treatment groups (1.7%, 0.6% and 0.6%, respectively).(1)

"Cardioversion is one treatment option for patients with atrial fibrillation and requires anticoagulation both prior to and following treatment in order to reduce the risk of stroke," said Rangadham Nagarakanti, MD, Louisiana State University School of Medicine.  "It's helpful to know that patients on PRADAXA who underwent cardioversion had low rates of stroke and systemic embolism
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
4. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Tenn. , Dec. 17, 2014  Strategic Health ... management software solutions, today announced a strategic agreement with ... New Jersey regional marketplace.  This ... enhance the health and wellness solutions QualCare brings to ... and the surrounding region. QualCare plans ...
(Date:12/17/2014)... , December 17, 2014 ... less than a hub of information concerning the biopharmaceutical Group,s ... A further addition to the recently launched institutional website ... has now been enriched by a new chapter in the ... A richly detailed and panoramic hub on the world ...
(Date:12/17/2014)... Ga. and RALEIGH, N.C. ... Trial Marketing Communications, LLC (CTMC), and Integrated Clinical ... patient recruitment and retention for clinical trials announce ... Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS will ... retention services to pharmaceutical, biotechnology and medical device ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... 2, 2011 Sigma-Aldrich Corporation (NASDAQ: SIAL ... in September: KeyBanc Capital Markets 2011 ... at the InterContinental, Boston, MA, presenting at 9:00 AM ... September 14, at the Grand Hyatt, New York, NY, ...
... Sept. 2, 2011 On September 2, 2011, Vycor Medical, ... Quarterly Reports with the Securities and Exchange Commission for the ... fiscal year ended December 31, 2009 Form 10-Q (2nd Amendment) ... (2nd Amendment) for the fiscal quarter ended June 30, 2010 ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2Vycor Medical, Inc. Files Restated Financial Statements 2Vycor Medical, Inc. Files Restated Financial Statements 3
(Date:12/19/2014)... LENEXA, Kan. (PRWEB) December 19, 2014 ... dedicated exclusively to healthcare providers, has been retained to ... for Johnson Memorial Hospital in Franklin, Ind. The top ... Smith has recently placed more than 900 healthcare executives ... 100-bed, county-owned, full service hospital providing care to the ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Pain Free ... is excited to announce a new Superior magnetic ... magnets. These are the strongest neodymium magnets for the ... Free Living developed the Superior Magnetics brand for the ... Free Living performs magnetic therapy using Superior Magnetic Jewelry ...
(Date:12/19/2014)... December 19, 2014 After a 13-year ... is again returning to the stage to entertain his ... for concert performances, and the successful tour has been ... announced. , Visit Ticketability.com for a ... Detroit shows at fair prices. , Music fans have ...
(Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- Being in good shape ... report. They looked at data from more than 57,000 ... underwent treadmill tests between 1991 and 2009. Those in ... of having high blood pressure at the start of the ... high levels of fitness. Of the more than 8,000 ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, ... ibuprofen, might slightly reduce your risk of developing a ... ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to reduce ... percent, the researchers concluded after reviewing nine prior studies. ... exposure. These painkillers "have potential as ...
Breaking Medicine News(10 mins):Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3
... LEXINGTON, Ky. (August 20, 2008) People at high risk ... or prevent the disease by taking certain food supplements and ... James W. Anderson, an internationally recognized authority on metabolic diseases ... nutrition at the University of Kentucky College of Medicine., ...
... says patients can still take the cholesterol-lowering drug ... drug regulators said Thursday that they were investigating ... to cancer. , The U.S. Food and Drug ... the agency was investigating a report from the ...
... BridgePoint Medical, LLC,s,partner, Charlotte Orthotic and Prosthetic Center ... COPC,s practitioner care team as Staff,Prosthetist and will ... facility., Amy is an ABC certified Prosthetist ... recently as a Staff Prosthetist / Orthotist with ...
... Aug. 22 AMN Healthcare Services,Inc. (NYSE: AHS ... make a presentation on Thursday, September 18, 2008 at ... Best Ideas Conference taking,place at the Omni Berkshire Place ... President and Chief Executive Officer of AMN,Healthcare, will present ...
... trends section contains insight on how the physician shortage is being ... ... (PRWEB) August 22, 2008 --- www.TDCpeople.com [The Delta Companies] ... Physician Recruiting Standard]], a free resource that provides a summary of ...
... understanding in the field of bioabsorbable polymers, Zeus presents free webinar ... ... August 22, 2008 -- Zeus, Inc., a leader in polymer science, ... cutting-edge bioabsorbables webinar entitled, "Bioabsorbable Polymers as Biomaterials." , , ,Presented ...
Cached Medicine News:Health News:'Nutraceuticals' could prevent diabetes 2Health News:FDA Investigates Possible Vytorin-Cancer Link 2Health News:FDA Investigates Possible Vytorin-Cancer Link 3Health News:Amy Street, Certified Prosthetist and Orthotist, Joins BridgePoint Medical Partner, Charlotte Orthotic and Prosthetic Center (COPC) 2Health News:AMN Healthcare Services to Present at the CL King 6th Annual Best Ideas Conference 2Health News:Physician Recruiting Standard Reveals Larger Populations Experiencing Increased Doctor Shortage 2Health News:Zeus Webinar: Bioabsorbable Polymers as Biomaterials 2
Foreign body spud very thin, lightly curved and rounded tip....
... premium high water content ... permeability. Standard one fit ... the following therapeutic conditions: ... bullous keratopathy, recurrent ulcers, ...
Bandage lenses....
Guthrie skin hook with 2 prongs....
Medicine Products: